AVITA Medical, Inc.
DE ˙ DB ˙ US05380C1027
6,35 € ↓ -0,05 (-0,78%)
2025-05-13
AKTIENPREIS
SecurityDE:51KA / AVITA Medical, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership19,075 shares
Latest Disclosed Value $ 65,808
Barclays Plc reports 2.83% decrease in ownership of 51KA / AVITA Medical, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 19,075 shares of AVITA Medical, Inc. (DE:51KA) valued at $65,808 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 19,631 shares of AVITA Medical, Inc.. This represents a change in shares of -2.83% during the quarter. The current value of the position is $121,126 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F AVITA MEDICAL COM 05380C102 19,075 -556 -2.83 66 -35.00 0.0000
2026-03-31 2025-09-30 13F/A-3 AVITA MEDICAL COM 05380C102 19,631 -26,928 -57.84 100 -59.35 0.0000
2026-03-19 2025-09-30 13F/A-2 AVITA MEDICAL COM 05380C102 37,503 -9,056 402 0.0001
2025-11-12 2025-09-30 13F AVITA MEDICAL COM 05380C102 19,631 -26,928 100 0.0000
2026-02-27 2025-06-30 13F/A-2 AVITA MEDICAL COM 05380C102 46,559 17,766 61.70 246 5.13 0.0001
2025-08-14 2025-06-30 13F/A-1 AVITA MEDICAL COM 05380C102 46,559 17,766 0 0.0001
2025-08-13 2025-06-30 13F AVITA MEDICAL COM 05380C102 46,559 17,766 0 0.0000
2026-03-17 2025-03-31 13F/A-1 AVITA MEDICAL COM 05380C102 28,793 -12,236 -29.82 234 -55.43 0.0001
2025-05-15 2025-03-31 13F AVITA MEDICAL COM 05380C102 28,793 -12,236 0 0.0001
2026-03-19 2024-12-31 13F/A-1 AVITA MEDICAL COM 05380C102 41,029 3,526 9.40 525 30.60 0.0001
2025-02-13 2024-12-31 13F AVITA MEDICAL COM 05380C102 41,029 3,526 1 0.0001
2026-03-31 2024-09-30 13F/A-2 AVITA MEDICAL COM 05380C102 37,503 28,979 339.97 402 500.00 0.0001
2024-11-19 2024-09-30 13F/A-1 AVITA MEDICAL COM 05380C102 37,503 28,979 0 0.0001
2024-11-15 2024-09-30 13F AVITA MEDICAL COM 05380C102 37,503 28,979 0 0.0000
2026-03-23 2024-06-30 13F/A-1 AVITA MEDICAL COM 05380C102 8,524 -11,812 -58.08 68 -79.38 0.0000
2024-08-14 2024-06-30 13F AVITA MEDICAL COM 05380C102 8,524 -11,812 0 0.0000
2026-03-24 2024-03-31 13F/A-1 AVITA MEDICAL COM 05380C102 20,336 -14,144 -41.02 326 -31.29 0.0001
2024-05-15 2024-03-31 13F AVITA MEDICAL COM 05380C102 20,336 -14,144 0 0.0001
2026-03-25 2023-12-31 13F/A-1 AVITA MEDICAL COM 05380C102 34,480 30,143 695.02 473 650.79 0.0002
2024-02-15 2023-12-31 13F AVITA MEDICAL COM 05380C102 34,480 30,143 0 0.0002
2026-03-26 2023-09-30 13F/A-1 AVITA MEDICAL COM 05380C102 4,337 -671 -13.40 63 -25.88 0.0000
2023-11-07 2023-09-30 13F AVITA MEDICAL COM 05380C102 4,337 -671 0 0.0000
2026-03-30 2023-06-30 13F/A-2 AVITA MEDICAL COM 05380C102 5,008 5,008 85 0.0001
2023-09-20 2023-06-30 13F/A-1 AVITA MEDICAL COM 05380C102 5,008 5,008 0 0.0001
2023-08-03 2023-06-30 13F AVITA MEDICAL COM 05380C102 5,008 5,008 0 0.0001
2022-11-03 2022-09-30 13F AVITA MEDICAL COM 05380C102 0 -90 -100.00 0 0.0000
2022-08-12 2022-06-30 13F AVITA MEDICAL COM 05380C102 90 -3,854 -97.72 0 -100.00
2022-05-16 2022-03-31 13F AVITA MEDICAL COM 05380C102 3,944 3,944 34 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.